Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0923620070070040186
Immune Network
2007 Volume.7 No. 4 p.186 ~ p.196
Enhancement of Antigen-specific Antibody and CD8+ T Cell Responses by Codelivery of IL-12-encapsulated Microspheres in Protein and Peptide Vaccination
Park Su-Hyung

Chang Jun
Yang Se-Hwan
Kim Hye-Ju
Kwak Hyun-Hee
Kim Byong-Moon
Lee Sung-Hee
Sung Young-Chul
Abstract
Background: Although IL-12 has been widely accepted to play a central role in the control of pathogen infection, the use of recombinant IL-12 (rIL-12) as a vaccine adjuvant has been known to be ineffective because of its rapid clearance in the body.

Methods: To investigate the effect of sustained release of IL-12 in vivo in the peptide and protein vaccination models, rIL-12 was encapsulated into poly (DL-lactic-co-glycolic acid) (PLGA).

Results: We found that codelivery of IL-12-encapsulated microspheres (IL-12EM) could dramatically increase not only antibody responses, but also antigen-specific CD4+ and CD8+ T cell responses. Enhanced immune responses were shown to be correlated with protective immunity against influenza and respiratory syncytial virus (RSV) virus challenge. Interestingly, the enhancement of CD8+ T cell response was not detectable when CD4+ T cell knockout mice were subjected to vaccination, indicating that the enhancement of the CD8+ T cell response by IL-12EM is dependent on CD4+ T cell "help".

Conclusion: Thus, IL-12EM could be applied as an adjuvant of protein and peptide vaccines to enhance protective immunity against virus infection
KEYWORD
Interleukin 12, PLGA microspheres, vaccine adjuvant, CTL response
FullTexts / Linksout information
  
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø